T2 Biosystems EV/EBITDA Ratio 2011-2026 | TTOO

Annual EV/EBITDA Ratio T2 Biosystems

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
0.533	-9.28	-1.58	-3.03	-3.13	-2.27	-3.31	-4.49	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
0.533	-9.28	-3.32

EV/EBITDA Ratio of other stocks in the Diagnostics research industry

Issuer	EV/EBITDA Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	0.387	-	-6.23 %	$ 30.6 M	Germany
Aspira Women's Health AWH	-2.63	-	-6.19 %	$ 10.5 M	USA
Agilent Technologies A	27.4	$ 115.39	-1.31 %	$ 35.1 B	USA
Biocept BIOC	-26.9	-	-13.05 %	$ 7.29 M	USA
BioNano Genomics BNGO	-7.71	$ 1.16	-1.69 %	$ 6.32 M	USA
Chembio Diagnostics CEMI	-1.23	-	0.22 %	$ 16.8 M	USA
DermTech DMTK	-2.44	-	-11.32 %	$ 2.94 M	USA
CareDx, Inc CDNA	-100	$ 16.69	-6.86 %	$ 889 M	USA
Oxford Immunotec Global PLC OXFD	-73.4	-	-	$ 562 M	Britain
Akumin AKU	28.1	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	58.3	-	-8.98 %	$ 14.8 K	USA
Burning Rock Biotech Limited BNR	-1.51	$ 16.25	0.06 %	$ 175 M	China
Exact Sciences Corporation EXAS	-20.8	-	-	$ 19.8 B	USA
Co-Diagnostics CODX	3.62	$ 4.4	101.83 %	$ 5.85 M	USA
Accelerate Diagnostics AXDX	-5.56	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	-21.2	$ 23.43	-6.99 %	$ 651 M	USA
Global Cord Blood Corporation CO	-3.52	-	-	$ 399 M	China
Fluidigm Corporation FLDM	-13.6	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	-2.67	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-2.67	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	22	$ 175.55	0.27 %	$ 8.7 B	USA
PRA Health Sciences, Inc. PRAH	20.8	-	-	$ 10.7 B	USA
Danaher Corporation DHR	20.1	$ 192.99	-1.63 %	$ 138 B	USA
Heska Corporation HSKA	141	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	-1.42	-	-20.0 %	$ 1.06 M	USA
Interpace Biosciences IDXG	-6.02	$ 2.3	16.02 %	$ 10.2 M	USA
Illumina ILMN	70.5	$ 123.67	-3.38 %	$ 19.7 B	USA
Fulgent Genetics FLGT	2.58	$ 15.02	-5.12 %	$ 454 M	USA
Koninklijke Philips N.V. PHG	55.6	$ 28.13	0.29 %	$ 20 B	Niderland
Guardant Health GH	-28.8	$ 87.17	-6.11 %	$ 10.9 B	USA
QIAGEN N.V. QGEN	13.2	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	-2.25	$ 2.74	0.37 %	$ 88.9 K	USA
Biomerica BMRA	-6.24	$ 2.2	2.33 %	$ 5.05 M	USA
ICON Public Limited Company ICLR	38	$ 106.7	0.15 %	$ 8.8 B	Irlanda
Check-Cap Ltd. CHEK	-0.674	-	-	$ 9.42 M	Israel
Laboratory Corporation of America Holdings LH	8.7	$ 273.26	-0.53 %	$ 22.7 B	USA
Celcuity CELC	-2.38	$ 124.64	6.58 %	$ 5.83 B	USA
Medpace Holdings MEDP	30.7	$ 501.5	-3.68 %	$ 14.5 B	USA
Lantheus Holdings LNTH	-187	$ 81.43	1.75 %	$ 5.5 B	USA
Motus GI Holdings MOTS	0.351	-	-34.28 %	$ 263 K	Israel
Myriad Genetics MYGN	-17.2	$ 4.44	-6.92 %	$ 411 M	USA
Quest Diagnostics Incorporated DGX	5.51	$ 197.82	-0.5 %	$ 22 B	USA
NeoGenomics NEO	-33.5	$ 7.94	-3.38 %	$ 1.02 B	USA
Neogen Corporation NEOG	40.3	$ 10.04	-2.95 %	$ 2.18 B	USA
ENDRA Life Sciences NDRA	0.831	$ 5.31	2.71 %	$ 4.18 M	USA
National Research Corporation NRC	21	$ 17.05	-1.22 %	$ 382 M	USA
Natera NTRA	-19.5	$ 203.0	-3.71 %	$ 20 B	USA
Invitae Corporation NVTA	-10.7	-	-	$ 21.2 M	USA
Organovo Holdings ONVO	0.992	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	0.274	-	-16.95 %	$ 1.54 M	USA